A phase II multicenter evaluation of ARQ 197 monotherapy in patients with relapsed or refractory germ cell tumors (GCTs).
D. R. Feldman
Research Funding - ArQule; Daiichi Sankyo
L. H. Einhorn
No relevant relationships to disclose
D. I. Quinn
No relevant relationships to disclose
A. Horwich
No relevant relationships to disclose
Y. Loriot
No relevant relationships to disclose
J. K. Joffe
No relevant relationships to disclose
D. J. Vaughn
No relevant relationships to disclose
A. Flechon
No relevant relationships to disclose
J. Hajdenberg
No relevant relationships to disclose
A. U. Pande
Employment or Leadership Position - Daiichi Sankyo
K. Liu
Employment or Leadership Position - Daiichi Sankyo
I. Gorbatchevsky
Employment or Leadership Position - Daiichi Sankyo
R. J. Motzer
Research Funding - ArQule; Daiichi Sankyo